info@healthcostinstitute.org

mediA@healthcostinstitute.org

  • X
  • LinkedIn
  • Link
Search
Health Care Cost Institute
  • Home
  • Data
    • ESI Data Access Hub
    • Data Tools
    • Healthy Marketplace Index
    • Price Transparency Tool
  • Research
    • Original Reports
    • Health Care Cost & Utilization Report 
    • Health Care Vitals
    • Latest HCCI Reports
  • About HCCI
    • About Us
    • HCCI Staff
    • CEO & President
    • Careers
    • Governing Board 
Search

Readmissions

  • Medicare Advantage Health Care Utilization – Hospital Readmissions

    Tags: Chronic Conditions, Inpatient Spending, Medicare Advantage, Readmissions
    Medicare Advantage Health Care Utilization – Hospital Readmissions
    Eric Barrette, Katharine McGraves-Lloyd
    November 1, 2016

     This data brief, reports on five readmission rate measures for the Medicare Advantage (MA) population: 30-day all-cause hospital-wide readmissions and 30-day all-cause readmissions following acute myocardial infarction (AMI), heart failure, chronic obstructive pulmonary disease (COPD), and pneumonia. The results show that MA readmission rates have been declining over the past five years.

    Read more: Medicare Advantage Health Care Utilization – Hospital Readmissions
    • Facebook
    • X
    • LinkedIn
    • Pinterest

Enhance your research using customized data analysis

Are you interested in a specific health care topic? HCCI can use our commercial and government data resources and unique analytic experience to help you. Just reach out!

Partner with us

About

We are a mission-driven, independent, nonprofit organization situated at the nexus of data, analytics, and action.

Contact

1100 G Street NW, Suite 600
Washington DC, 20005

info@healthcostinstitute.org
media@healthcostinstitute.org

Research

HCCI Publications
Research Resources

Data

Data Access Hub
Data Tools

Quick Links

Partner with HCCI
HCCI Newsletter
Careers

  • LinkedIn
  • X
  • Link
  • Bluesky

© 2025 Health Care Cost Institute Inc.
Unless explicitly noted, the content on this website is licensed under a Creative Commons Attribution Non-Commercial No Derivatives 4.0 License

Scroll to Top